Champions Oncology (CSBR) Current Leases (2018 - 2026)

Champions Oncology has reported Current Leases for 9 years, with the latest figure at $1.5 million in Q2 2026.

• On a quarterly basis, Current Leases rose 3.33% year-over-year to $1.5 million in Q2 2026; TTM through Apr 2026 was $1.5 million, a 3.33% increase from a year earlier, with the FY2026 full-year figure at $1.5 million, up 3.33% from the prior year.
• Current Leases was $1.5 million for Q2 2026 at Champions Oncology, down from $1.5 million in the prior quarter.
• The five-year high for Current Leases was $1.5 million in Q1 2026, with the low at $1.0 million in Q1 2022.
• Average Current Leases over 5 years is $1.3 million, with a median of $1.3 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2026: Current Leases surged 61.46% in 2022, then advanced 3.33% in 2026.
• Over 5 years, Current Leases stood at $1.1 million in 2022, then grew by 12.53% to $1.3 million in 2023, then climbed by 9.88% to $1.4 million in 2024, then gained by 8.85% to $1.5 million in 2025, then dropped by 0.33% to $1.5 million in 2026.
• The last three Current Leases figures came in at $1.5 million (Q2 2026), $1.5 million (Q1 2026), and $1.5 million (Q4 2025), per Business Quant data.